Telcagepant (MK-0974) Treatment of Migraine in Participants With Stable Vascular Disease (MK-0974-034)

Clinical trial NCT00662818 · COMPLETED

Trial details

NCT number: NCT00662818
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Migraine Disorders Heart Disease Cerebrovascular Accident TIA (Transient Ischemic Attack)Vascular Diseases Peripheral Vascular Diseases

Start date: 2008-03-17
Primary completion: 2009-09-02
Enrollment: 165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.